IRIS UniCatt

De Marinis Grasso, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.347
EU - Europa 5.859
AS - Asia 5.420
SA - Sud America 1.176
Continente sconosciuto - Info sul continente non disponibili 281
AF - Africa 142
OC - Oceania 11
Totale 21.236
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.111
SG - Singapore 2.310
DE - Germania 2.205
CN - Cina 1.300
BR - Brasile 941
SE - Svezia 821
IT - Italia 670
VN - Vietnam 611
UA - Ucraina 558
FR - Francia 454
GB - Regno Unito 274
IE - Irlanda 227
IN - India 223
BD - Bangladesh 197
FI - Finlandia 181
ID - Indonesia 161
JP - Giappone 139
RU - Federazione Russa 134
HK - Hong Kong 123
CA - Canada 121
AR - Argentina 90
TR - Turchia 65
MX - Messico 57
IQ - Iraq 55
NL - Olanda 54
PL - Polonia 49
BE - Belgio 46
EC - Ecuador 39
ES - Italia 38
AT - Austria 35
PK - Pakistan 33
ZA - Sudafrica 31
MA - Marocco 25
VE - Venezuela 25
SA - Arabia Saudita 23
CL - Cile 22
CO - Colombia 20
UZ - Uzbekistan 20
KR - Corea 18
AE - Emirati Arabi Uniti 16
EG - Egitto 14
JM - Giamaica 14
PE - Perù 14
KZ - Kazakistan 13
PT - Portogallo 13
PY - Paraguay 13
RO - Romania 13
AL - Albania 12
CH - Svizzera 12
IR - Iran 12
JO - Giordania 12
TN - Tunisia 12
MY - Malesia 11
SN - Senegal 11
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
CI - Costa d'Avorio 9
CR - Costa Rica 9
KE - Kenya 9
LT - Lituania 9
AU - Australia 8
DZ - Algeria 8
PH - Filippine 8
ET - Etiopia 7
IL - Israele 7
LB - Libano 7
MD - Moldavia 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
LK - Sri Lanka 6
NP - Nepal 6
QA - Qatar 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
HN - Honduras 5
NO - Norvegia 5
BG - Bulgaria 4
GE - Georgia 4
GT - Guatemala 4
HU - Ungheria 4
NG - Nigeria 4
OM - Oman 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
DK - Danimarca 3
GR - Grecia 3
KG - Kirghizistan 3
LV - Lettonia 3
RS - Serbia 3
AO - Angola 2
BS - Bahamas 2
EU - Europa 2
HR - Croazia 2
KW - Kuwait 2
ME - Montenegro 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
Totale 20.929
Salva come PNG Salva come JPEG
Città #
Singapore 1.224
Ashburn 873
Chandler 847
San Jose 766
New York 255
Beijing 239
Jacksonville 225
Dublin 218
Ho Chi Minh City 216
San Mateo 214
Ann Arbor 206
Los Angeles 198
Nanjing 149
Rome 142
Hanoi 141
Jakarta 138
Lauterbourg 132
Wilmington 130
Hefei 124
Tokyo 112
Boston 111
Hong Kong 108
Milan 99
The Dalles 99
Nürnberg 98
Munich 94
Houston 92
São Paulo 92
Dallas 91
Marseille 90
Chicago 88
Moscow 88
Frankfurt am Main 81
Dearborn 79
Santa Clara 72
Woodbridge 69
Princeton 66
Buffalo 59
Helsinki 57
Seattle 56
Lawrence 53
Cattolica 52
Redwood City 51
Nanchang 50
St Louis 50
Kent 49
Bremen 48
Tukwila 48
Boardman 47
Brussels 44
Mountain View 43
Zhengzhou 43
Atlanta 42
Montreal 41
University Park 40
Brooklyn 36
Denver 36
Hangzhou 36
Detroit 35
Izmir 35
Orem 35
Shanghai 35
Delhi 34
Rio de Janeiro 34
Da Nang 32
Fairfield 31
Warsaw 30
Norwalk 28
Shenyang 28
Lancaster 27
Paris 27
Turku 27
Fremont 26
London 25
Nuremberg 24
Changsha 23
Guangzhou 23
Haiphong 22
Leawood 22
San Francisco 22
Tianjin 22
Belo Horizonte 21
Chennai 21
Kunming 21
Hebei 20
Las Vegas 20
Baghdad 19
Düsseldorf 19
Philadelphia 19
Redmond 19
Amsterdam 18
Jiaxing 18
Phoenix 18
Poplar 18
Toronto 18
Stockholm 17
Tashkent 17
Cambridge 16
Mumbai 16
Porto Alegre 16
Totale 10.045
Salva come PNG Salva come JPEG
Nome #
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 499
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries 329
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 311
The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel 300
Isolated growth hormone deficiency: clinical entity? 290
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 282
Growth hormone in inflammatory bowel disease 269
Predictors of morbidity and mortality in acromegaly, an Italian survey. 262
Evaluation of antioxidants systems in pituitary-adrenal axis diseases. 259
Double pituitary adenomas 241
Seminal antioxidant capacity in pre- and postoperative varicocele 238
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 228
Evaluation of Antioxidant systems (Coenzyme Q10 and total antioxidant capacity) in morbidy obesity before and after biliopancreatic diversion 228
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 218
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 213
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 208
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 206
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 205
Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. 204
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 202
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 202
Male fertility and reduction in semen parameters: A single tertiary-care center experience 197
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography 193
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 192
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography. 186
Primary hyperparathyroidism. Our experience 183
NOVEL BIOMARKERS OF ANDROGEN DEFICIENCY FROM SEMINAL PLASMA PROFILING USING HIGH-RESOLUTION MASS SPECTROMETRY. 182
[Immunogenetic and functional study of first-degree relatives of patients with type I diabetes mellitus for identifying prediabetic subjects] 180
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 177
Pancreatic metastases from a bronchopulmonary carcinoid diagnosed by endoscopic ultrasonography-guided fine-needle tissue acquisition 172
[Coexistence of hyperthyroidism and thyroid carcinoma. Description of a clinical case] 168
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 167
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 166
Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade 164
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 164
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. 164
Xanthogranuloma of the sellar region: A rare tumor. Case illustration and literature review 164
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 163
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 161
Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. 161
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 159
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 155
Proteomic approach in the identification of fertility pattern in seminal plasma of fertile men 155
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 155
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 154
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 154
Effects of Testosterone on antioxidant systems in male secondary hypogonadism. 153
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 152
Plasma prolactin response to gonadotropin-releasing hormone during benzodiazepine treatment 151
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin 151
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 150
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 150
Naloxone inhibition of postprandial growth hormone releasing hormone-induced growth hormone release in obesity 149
Hypothalamitis: a diagnostic and therapeutic challenge 147
Fertility and hypopituitarism 146
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 146
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 145
GH receptor isoforms and skeletal fragility in acromegaly 142
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 142
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 139
Increased total antioxidant capacity in seminal plasma of varicocele patients: a multivariate analysis 136
Endocrine evaluation of patients with benign lumps of the breast 136
ACTH-dependent Cushing syndrome: The potential benefits of simultaneous bilateral posterior retroperitoneoscopic adrenalectomy 135
Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure 135
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 135
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 134
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 133
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 133
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 131
Corticotropin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle 131
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 130
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 130
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 130
Prevalence of vertebral fractures in men with acromegaly 129
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 129
Genes of the “regulation of lymphocyte activation” pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors 127
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 127
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 127
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 123
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 122
Effects of high-dose octreotide lar on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy 122
Empty sella syndrome: Multiple endocrine disorders. 121
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 120
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 119
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 119
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 117
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 116
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 116
Reciprocal regulation of microrna-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions 116
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 115
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition 115
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. 115
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 114
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 113
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 113
Understanding the effect of acromegaly on the human skeleton. 112
Acromegaly in the elderly patients 112
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: A multicenter study 111
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 111
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 110
Totale 16.613
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.110
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.103 0 96 20 79 112 45 26 175 50 66 183 251
2022/20232.397 302 346 194 337 172 283 135 183 266 42 77 60
2023/20241.052 61 319 21 43 51 163 37 19 28 34 118 158
2024/20252.512 63 63 170 81 173 85 28 118 412 221 498 600
2025/20267.910 1.046 268 516 943 1.166 393 1.280 408 439 577 620 254
2026/20271.312 508 804 0 0 0 0 0 0 0 0 0 0
Totale 21.236